Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Protalix BioTherapeutics Net Income 2006-2018 | PLX

Protalix BioTherapeutics net income from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Protalix BioTherapeutics Annual Net Income
(Millions of US $)
2018 $-26
2017 $-83
2016 $-29
2015 $58
2014 $-30
2013 $-28
2012 $-12
2011 $-37
2010 $-29
2009 $-31
2008 $-22
2007 $-32
2006 $-9
2005 $-6
Protalix BioTherapeutics Quarterly Net Income
(Millions of US $)
Q4 2018 $-5
Q3 2018 $-5
Q2 2018 $-8
Q1 2018 $-7
Q4 2017 $-13
Q3 2017 $-11
Q2 2017 $0
Q1 2017 $-59
Q4 2016 $-3
Q3 2016 $-7
Q2 2016 $-11
Q1 2016 $-9
Q4 2015 $73
Q3 2015 $-4
Q2 2015 $-5
Q1 2015 $-6
Q4 2014 $-8
Q3 2014 $-8
Q2 2014 $-6
Q1 2014 $-7
Q4 2013 $-11
Q3 2013 $-6
Q2 2013 $-7
Q1 2013 $-4
Q4 2012 $-10
Q3 2012 $-5
Q2 2012 $10
Q1 2012 $-6
Q4 2011 $-9
Q3 2011 $-9
Q2 2011 $-14
Q1 2011 $-5
Q4 2010 $-9
Q3 2010 $-2
Q2 2010 $-10
Q1 2010 $-8
Q4 2009 $-15
Q3 2009 $-6
Q2 2009 $-5
Q1 2009 $-5
Q4 2008 $-7
Q3 2008 $-6
Q2 2008 $-4
Q1 2008 $-5
Q4 2007 $-15
Q3 2007 $-5
Q2 2007 $-9
Q1 2007 $-3
Q4 2006 $-3
Q3 2006 $-2
Q2 2006 $-2
Q1 2006 $-2
Q4 2005 $-6
Q3 2005 $-0
Q2 2005 $-0
Q1 2005 $-0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.062B $0.034B
Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx(R). Protalix's unique expression system presents a proprietary method for developing recombinant proteins in a cost-effective, industrial-scale manner. Protalix's first product manufactured by ProCellEx, taliglucerase alfa, was approved for marketing by the U.S. Food and Drug Administration (FDA) in May 2012 and, subsequently, by the regulatory authorities of other countries. Protalix has licensed to Pfizer Inc. the worldwide development and commercialization rights for taliglucerase alfa, excluding Brazil, where Protalix retains full rights.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.824B 12.37
Gilead Sciences (GILD) United States $80.063B 10.19
Celgene (CELG) United States $65.398B 12.09
Illumina (ILMN) United States $46.205B 54.99
Biogen (BIIB) United States $44.141B 8.26
Vertex Pharmaceuticals (VRTX) United States $44.121B 59.10
Regeneron Pharmaceuticals (REGN) United States $37.204B 17.28
Alexion Pharmaceuticals (ALXN) United States $29.071B 18.02
Incyte (INCY) United States $15.753B 147.04
BioMarin Pharmaceutical (BMRN) United States $15.249B 0.00
Exact Sciences (EXAS) United States $11.964B 0.00
Seattle Genetics (SGEN) United States $11.154B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.133B 52.39
Alnylam Pharmaceuticals (ALNY) United States $9.075B 0.00
QIAGEN (QGEN) Netherlands $8.689B 28.75
Moderna (MRNA) United States $8.475B 0.00
Sarepta Therapeutics (SRPT) United States $8.424B 0.00
Bluebird Bio (BLUE) United States $7.503B 0.00
Bio-Techne Corp (TECH) United States $7.211B 48.58
BeiGene (BGNE) Cayman Islands $7.166B 0.00
Exelixis (EXEL) United States $6.193B 14.37
Amarin (AMRN) Ireland $5.971B 0.00
Galapagos (GLPG) Belgium $5.750B 0.00
Guardant Health (GH) United States $5.628B 0.00
Alkermes (ALKS) Ireland $5.452B 0.00
Array BioPharma (ARRY) United States $4.975B 0.00
Horizon Pharma Public (HZNP) Ireland $4.637B 13.74
Ascendis Pharma (ASND) Denmark $4.552B 0.00
Spark Therapeutics (ONCE) United States $4.201B 0.00
China Biologic Products (CBPO) China $3.927B 24.33
Ultragenyx Pharmaceutical (RARE) United States $3.884B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.851B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.459B 0.00
Allogene Therapeutics (ALLO) United States $3.348B 0.00
Blueprint Medicines (BPMC) United States $3.328B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.122B 0.00
Global Blood Therapeutics (GBT) United States $3.121B 0.00
Immunomedics (IMMU) United States $3.072B 0.00
Amicus Therapeutics (FOLD) United States $2.942B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.796B 0.00
Emergent Biosolutions (EBS) United States $2.753B 22.90
Intercept Pharmaceuticals (ICPT) United States $2.709B 0.00
Ligand Pharmaceuticals (LGND) United States $2.532B 18.91
Akcea Therapeutics (AKCA) United States $2.491B 0.00
Repligen (RGEN) United States $2.477B 75.93
Genomic Health (GHDX) United States $2.403B 61.43
Insmed (INSM) United States $2.400B 0.00
Reata Pharmaceuticals (RETA) United States $2.357B 0.00
Halozyme Therapeutics (HALO) United States $2.350B 0.00
Myriad Genetics (MYGN) United States $2.348B 23.92
Denali Therapeutics (DNLI) United States $2.308B 0.00
Arena Pharmaceuticals (ARNA) United States $2.271B 0.00
Mirati Therapeutics (MRTX) United States $2.261B 0.00
Medicines (MDCO) United States $2.176B 0.00
Acceleron Pharma (XLRN) United States $2.136B 0.00
UniQure (QURE) Netherlands $2.058B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.016B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $2.000B 0.00
AnaptysBio (ANAB) United States $1.977B 0.00
REGENXBIO (RGNX) United States $1.925B 19.99
MyoKardia (MYOK) United States $1.923B 0.00
NeoGenomics (NEO) United States $1.905B 153.69
Audentes Therapeutics (BOLD) United States $1.732B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.689B 0.00
Allakos (ALLK) United States $1.643B 0.00
Atara Biotherapeutics (ATRA) United States $1.534B 0.00
Alector (ALEC) United States $1.487B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.464B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.418B 0.00
Innoviva (INVA) United States $1.387B 3.82
Cambrex (CBM) United States $1.355B 14.59
Lion Biotechnologies (IOVA) United States $1.345B 0.00
InflaRx (IFRX) Germany $1.328B 0.00
Editas Medicine (EDIT) United States $1.326B 0.00
Rubius Therapeutics (RUBY) United States $1.320B 0.00
Puma Biotechnology (PBYI) United States $1.311B 0.00
Aimmune Therapeutics (AIMT) United States $1.300B 0.00
Myovant Sciences (MYOV) United Kingdom $1.274B 0.00
Sangamo Therapeutics (SGMO) United States $1.215B 0.00
Apellis Pharmaceuticals (APLS) United States $1.194B 0.00
Epizyme (EPZM) United States $1.138B 0.00
Gossamer Bio (GOSS) United States $1.096B 0.00
Fate Therapeutics (FATE) United States $1.095B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.071B 0.00
Clovis Oncology (CLVS) United States $1.053B 0.00
Codexis (CDXS) United States $1.041B 0.00
Eidos Therapeutics (EIDX) United States $1.012B 0.00
Coherus BioSciences (CHRS) United States $1.005B 0.00
NGM BIOPHARMACT (NGM) United States $1.001B 0.00
Genfit SA (GNFT) France $0.969B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.937B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.934B 0.00
Twist Bioscience (TWST) United States $0.930B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.924B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.918B 0.00
RA PHARMCTL INC (RARX) United States $0.913B 0.00
WAVE Life Sciences (WVE) Singapore $0.913B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.885B 35.79
Rhythm Pharmaceuticals (RYTM) United States $0.867B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.831B 0.00
ANI Pharmaceuticals (ANIP) United States $0.830B 15.18
Cellectis (CLLS) France $0.822B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.803B 0.00
Retrophin (RTRX) United States $0.801B 0.00
Vericel (VCEL) United States $0.771B 0.00
Intellia Therapeutics (NTLA) United States $0.759B 0.00
Cara Therapeutics (CARA) United States $0.753B 0.00
Arvinas (ARVN) United States $0.734B 0.00
Athenex (ATNX) United States $0.721B 0.00
Intra-Cellular Therapies (ITCI) United States $0.721B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.718B 0.00
G1 THERAPEUTICS (GTHX) United States $0.704B 0.00
Principia Biopharma (PRNB) United States $0.693B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.675B 0.00
ObsEva SA (OBSV) Switzerland $0.641B 0.00
Precision BioSciences (DTIL) United States $0.627B 0.00
Stemline Therapeutics (STML) United States $0.621B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.613B 0.00
MeiraGTx Holdings (MGTX) United States $0.612B 0.00
Viking Therapeutics (VKTX) United States $0.603B 0.00
Zealand Pharma (ZEAL) Denmark $0.587B 6.53
Heska (HSKA) United States $0.585B 52.49
Revance Therapeutics (RVNC) United States $0.578B 0.00
Kura Oncology (KURA) United States $0.570B 0.00
DBV Technologies (DBVT) France $0.556B 0.00
Magenta Therapeutics (MGTA) United States $0.548B 0.00
Zymeworks (ZYME) Canada $0.540B 0.00
Synthorx (THOR) United States $0.534B 0.00
Axsome Therapeutics (AXSM) United States $0.534B 0.00
Acorda Therapeutics (ACOR) United States $0.532B 6.90
Mesoblast (MESO) Australia $0.516B 0.00
Cytokineticsorporated (CYTK) United States $0.516B 0.00
UROGEN PHARMA (URGN) United States $0.510B 0.00
Replimune (REPL) United States $0.485B 0.00
AVROBIO (AVRO) United States $0.481B 0.00
Arcus Biosciences (RCUS) United States $0.480B 0.00
Krystal Biotech (KRYS) United States $0.478B 0.00
Scholar Rock Holding (SRRK) United States $0.472B 0.00
MediciNova (MNOV) United States $0.470B 0.00
Anika Therapeutics (ANIK) United States $0.459B 17.38
Sorrento Therapeutics (SRNE) United States $0.455B 0.00
CytomX Therapeutics (CTMX) United States $0.450B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.446B 0.00
KALEIDO BIOSCI (KLDO) $0.445B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.443B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.437B 0.00
Prothena (PRTA) Ireland $0.436B 0.00
PDL BioPharma (PDLI) United States $0.432B 9.63
Five Prime Therapeutics (FPRX) United States $0.432B 0.00
Senesco Technologies (ELOX) United States $0.431B 0.00
Dynavax Technologies (DVAX) United States $0.426B 0.00
CYCLERION THERA (CYCN) United States $0.425B 0.00
Adverum Biotechnologies (ADVM) United States $0.418B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.410B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.399B 0.00
Abeona Therapeutics (ABEO) United States $0.398B 0.00
STEALTH BIOTHER (MITO) United States $0.391B 0.00
Kezar Life Sciences (KZR) United States $0.382B 0.00
Inovio Pharmaceuticals (INO) United States $0.371B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Albireo Pharma (ALBO) United States $0.370B 0.00
Merus (MRUS) Netherlands $0.362B 0.00
Gritstone Oncology (GRTS) United States $0.359B 0.00
Agenus (AGEN) United States $0.353B 0.00
BioDelivery Sciences (BDSI) United States $0.349B 0.00
Geron (GERN) United States $0.349B 0.00
Kindred Biosciences (KIN) United States $0.343B 0.00
UNITY Biotechnology (UBX) $0.335B 0.00
Solid Biosciences (SLDB) United States $0.332B 0.00
XBiotech (XBIT) United States $0.331B 0.00
AC Immune SA (ACIU) Switzerland $0.322B 0.00
Constellation Pharmaceuticals (CNST) United States $0.317B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.315B 0.00
PHASEBIO PHARMA (PHAS) United States $0.313B 0.00
BeyondSpring (BYSI) United States $0.313B 0.00
Cellular Biomedicine (CBMG) United States $0.297B 0.00
MannKind (MNKD) United States $0.287B 0.00
Aduro Biotech (ADRO) United States $0.285B 0.00
LogicBio Therapeutics (LOGC) United States $0.284B 0.00
Seres Therapeutics (MCRB) United States $0.281B 0.00
Kadmon Holdings (KDMN) United States $0.280B 0.00
Kodiak Sciences (KOD) United States $0.274B 0.00
ResTORbio (TORC) United States $0.271B 0.00
Evelo Biosciences (EVLO) United States $0.263B 0.00
Avid Bioservices (CDMO) United States $0.258B 0.00
Strongbridge Biopharma (SBBP) United States $0.254B 0.00
Enochian BioSciences (ENOB) United States $0.252B 0.00
Kala Pharmaceuticals (KALA) United States $0.252B 0.00
Arsanis (XFOR) United States $0.252B 0.00
Urovant Sciences (UROV) United States $0.250B 0.00
Kamada (KMDA) Israel $0.246B 11.09
ChromaDex (CDXC) United States $0.244B 0.00
Athersys (ATHX) United States $0.242B 0.00
Cerecor (CERC) United States $0.242B 0.00
Novavax (NVAX) United States $0.240B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.239B 0.00
Sutro Biopharma (STRO) United States $0.230B 0.00
Protagonist Therapeutics (PTGX) United States $0.228B 0.00
Syros Pharmaceuticals (SYRS) United States $0.228B 0.00
Palatin Technologies (PTN) United States $0.227B 112.00
ADMA Biologics Inc (ADMA) United States $0.222B 0.00
Cel-Sci (CVM) United States $0.221B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.220B 0.00
Celcuity (CELC) United States $0.219B 0.00
OSMOTICA PHARM (OSMT) United States $0.219B 0.00
OvaScience (MLND) United States $0.216B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.213B 0.00
Spero Therapeutics (SPRO) United States $0.213B 0.00
Axovant Sciences (AXGT) United Kingdom $0.211B 0.00
Gamida Cell (GMDA) Israel $0.210B 0.00
Intec Pharma (NTEC) Israel $0.204B 0.00
Celyad SA (CYAD) Belgium $0.202B 0.00
Mersana Therapeutics (MRSN) United States $0.201B 0.00
TOCAGEN INC (TOCA) United States $0.198B 0.00
VBI Vaccines (VBIV) United States $0.194B 0.00
Synlogic (SYBX) United States $0.193B 0.00
CorMedix Inc (CRMD) United States $0.190B 0.00
BioTime (BTX) United States $0.187B 0.00
Pfenex (PFNX) United States $0.185B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.181B 0.00
Compugen (CGEN) Israel $0.180B 0.00
Cue Biopharma (CUE) United States $0.175B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.175B 0.00
Enzo Biochem (ENZ) United States $0.171B 0.00
Menlo Therapeutics (MNLO) United States $0.169B 0.00
BioXcel Therapeutics (BTAI) United States $0.168B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
Mustang Bio (MBIO) United States $0.160B 0.00
Verastem (VSTM) United States $0.157B 0.00
Arbutus Biopharma (ABUS) Canada $0.156B 0.00
Chiasma (CHMA) United States $0.149B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.148B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.143B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.143B 0.00
Anavex Life Sciences (AVXL) United States $0.140B 0.00
Allena Pharmaceuticals (ALNA) United States $0.137B 0.00
Trevena (TRVN) United States $0.136B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.134B 0.00
Eton Pharmaceuticals (ETON) United States $0.130B 0.00
Liquidia Technologies (LQDA) United States $0.128B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.127B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.127B 0.00
Provention Bio (PRVB) United States $0.126B 0.00
Checkpoint Therapeutics (CKPT) United States $0.126B 0.00
Aptinyx (APTX) United States $0.125B 0.00
VolitionRX (VNRX) Singapore $0.125B 0.00
Organovo Holdings (ONVO) United States $0.119B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.118B 0.00
Neothetics (EVFM) United States $0.113B 0.00
XOMA (XOMA) United States $0.106B 0.00
Unum Therapeutics (UMRX) United States $0.106B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.106B 0.00
Fortress Biotech (FBIO) United States $0.104B 0.00
Catalyst Biosciences (CBIO) United States $0.102B 0.00
INMUNE BIO INC (INMB) United States $0.101B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.099B 0.00
Cohbar (CWBR) United States $0.096B 0.00
Dyadic (DYAI) United States $0.095B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.093B 0.00
Selecta Biosciences (SELB) United States $0.093B 0.00
Equillium (EQ) United States $0.092B 0.00
Signal Genetics (MGEN) United States $0.088B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.087B 0.00
NantKwest (NK) United States $0.086B 0.00
Applied Genetic Technologies (AGTC) United States $0.085B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.085B 0.00
Cocrystal Pharma (COCP) United States $0.084B 89.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
SESEN BIO, INC (SESN) United States $0.084B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.083B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.082B 0.00
Alcobra (ARCT) United States $0.081B 0.00
Eyenovia (EYEN) United States $0.078B 0.00
Aptose Biosciences (APTO) Canada $0.076B 0.00
OVID THERAPEUTC (OVID) United States $0.075B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
Vaccinex (VCNX) United States $0.073B 0.00
Orgenesis (ORGS) United States $0.071B 0.00
ARAVIVE, INC (ARAV) United States $0.071B 0.00
Zosano Pharma (ZSAN) United States $0.067B 0.00
Pluristem Therapeutics (PSTI) Israel $0.065B 0.00
Cidara Therapeutics (CDTX) United States $0.064B 0.00
AEterna Zentaris (AEZS) United States $0.063B 15.40
Apricus Biosciences (SEEL) United States $0.063B 0.00
Alimera Sciences (ALIM) United States $0.063B 0.00
NewLink Genetics (NLNK) United States $0.062B 0.00
VTv Therapeutics (VTVT) United States $0.061B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.061B 0.00
Moleculin Biotech (MBRX) United States $0.060B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.060B 0.00
Ophthotech (ISEE) United States $0.059B 0.00
Curis (CRIS) United States $0.059B 0.00
Evogene (EVGN) Israel $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.058B 0.00
ScPharmaceuticals (SCPH) United States $0.057B 0.00
HOTH THERAPEUTC (HOTH) United States $0.052B 0.00
Prima BioMed (IMMP) Australia $0.052B 0.00
AquaBounty Technologies (AQB) United States $0.050B 0.00
Entera Bio (ENTX) Israel $0.049B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.049B 0.00
AZURRX BIOPHARM (AZRX) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Celldex Therapeutics (CLDX) United States $0.047B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.046B 0.00
Celsion (CLSN) United States $0.046B 0.00
VistaGen Therapeutics (VTGN) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Bionano Genomics (BNGO) United States $0.043B 0.00
Bellerophon Therapeutics (BLPH) United States $0.043B 0.00
ANCHIANO THERAP (ANCN) Israel $0.043B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.042B 0.00
DiaMedica Therapeutics (DMAC) United States $0.041B 0.00
VIVUS (VVUS) United States $0.039B 0.00
OncoSec Medical (ONCS) United States $0.038B 0.00
Leap Therapeutics (LPTX) United States $0.037B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
Aptevo Therapeutics (APVO) United States $0.032B 0.00
Motif Bio Plc (MTFB) United States $0.032B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Sophiris Bio (SPHS) United States $0.028B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
GTx (GTXI) United States $0.027B 0.00
Novelion Therapeutics (NVLN) Canada $0.026B 0.00
Aileron Therapeutics (ALRN) United States $0.026B 0.00
Vical (VICL) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.025B 0.00
Adial Pharmaceuticals (ADIL) United States $0.024B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.024B 0.00
Oragenics (OGEN) United States $0.023B 0.00
Fibrocell Science Inc (FCSC) United States $0.022B 0.00
ATyr Pharma (LIFE) United States $0.021B 0.00
Galena Biopharma (SLS) United States $0.021B 0.00
Benitec Biopharma (BNTC) Australia $0.020B 0.00
IMMURON LTD (IMRN) Australia $0.020B 0.00
Advaxis (ADXS) United States $0.020B 0.00
TRACON Pharmaceuticals (TCON) United States $0.020B 0.00
CytRx (CYTR) United States $0.019B 0.00
TrovaGene (TROV) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
Histogenics (HSGX) United States $0.017B 0.00
Vital Therapies (IMUX) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Oncobiologics (OTLK) United States $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
BioPharmX (BPMX) United States $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 5.96
Dare Bioscience (DARE) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
Flex Pharma (FLKS) United States $0.010B 0.00
Neuralstem (CUR) United States $0.010B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
Edge Therapeutics (PDSB) United States $0.010B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Pulmatrix (PULM) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
Cellect Biotechnology (APOP) Israel $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00